Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Debt / NOTE 1.500% 4/1
-
Market price (% of par)
-
102.35%
-
Total 13F principal
-
$172,807,000
-
Principal change
-
+$172,807,000
-
Total reported market value
-
$177,229,715
-
Number of holders
-
25
-
Value change
-
+$177,229,715
-
Number of buys
-
25
Institutional Holders of COHERUS BIOSCIENCES INC - NOTE 1.500% 4/1 as of Q2 2021
As of 30 Jun 2021,
COHERUS BIOSCIENCES INC - NOTE 1.500% 4/1 was held by
25 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$172,807,000
in principal (par value) of the bond.
The largest 10 bondholders included
Opti Capital Management, LP, UBS ASSET MANAGEMENT AMERICAS INC, LAZARD ASSET MANAGEMENT LLC, CITADEL ADVISORS LLC, DEUTSCHE BANK AG\, CNH PARTNERS LLC, D. E. Shaw & Co., Inc., WOLVERINE ASSET MANAGEMENT LLC, WELLS FARGO & COMPANY/MN, and CALAMOS ADVISORS LLC.
This page lists
25
institutional bondholders reporting positions
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.